Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China
The study demonstrated the difference in clinical and laboratory parameters between patients infected with Omicron BA.2.76 and BA.5.1, as well as the safety and efficacy of Azvudine therapy. Our study linked patient manifestations to Omicron subvariant, treatment, and clinical outcomes, which is conducive to healthcare providers/policymakers to revise and implement appropriate countermeasures, facilitating appropriately advise for individuals with Omicron subvariant infections.
Authors
- Huimin Yan (ORCID: https://orcid.org/0000-0003-3158-2536)
- Haoting Zhan (ORCID: https://orcid.org/0000-0001-5934-9141)
- Yongmei Liu (ORCID: https://orcid.org/0000-0002-0139-5900)
- Yongzhe Li (ORCID: https://orcid.org/0000-0002-0046-5276)
- Wei Feng (ORCID: https://orcid.org/0000-0003-4564-5091)
- Erhei Dai (ORCID: https://orcid.org/0000-0001-8835-6199)
- Tao Huang (ORCID: https://orcid.org/0000-0002-5842-3386)
- Qian Zhang (ORCID: https://orcid.org/0000-0002-8269-9315)
- Wenfang Yuan
- Huixia Gao
Institutions
- Hebei Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Fifth Hospital of Shijiazhuang (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3389/fmed.2024.1511227
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Peking Union Medical College Hospital